References
- Aellig W. H. Venoconstrictor effect of dihydroergotamine in superficial hand veins. Europ. J. clin. Pharmacol 1974; 7: 137–9
- Lindblad B., Bergqvist D. Central haemodynamic effects of dextran 70, dihydroergotamine and their combination. A study in dogs. Acta Chir. Scand 1983; 149: 459–65
- Lindblad B., Bergqvist D. Tissue blood flow and blood flow distribution after administration of dextran 70, dihydroergotamine and their combination. A study using the radioactive microsphere technique. Acta Chir. Scand 1983; 149: 467–72
- Lindblad B., Bergqvist D., Hedner U. The effects of dihydroergotamine on platelets, coagulation and fibrinolysis, studied in healthy humans and in dogs. Thromb. Res 1983; 32: 35–44
- Lindblad B., Bergqvist D., Efsing H. O., Hallböök T., Lindell S-E. Changes in peripheral haemodynamics induced by dextran 70, dihydroergotamine, and their combination. A study using ultrasonic, serial phlebography, plethysmography and isotope clearance techniques. VASA, in press
- Loew D. M., van Deusen E. B., Meir-Ruge W. Effects on central nervous system. Ergot alkaloids and related compunds, B. Berde, H. O. Schild. Springer Verlag, Berlin, Heidelberg, New York 1978; 421–531
- Nowak G., Markwardt F. The influence of drugs on disseminated intravascular coagulation (DIC)V. Effects of α-adrenoceptor blocking agents on thrombin -induced DIC in rats. Thromb. Res 1981; 22: 417–25
- Mellander S., Nordenfelt I. Comparative effects of dihydroergotamine and noradrenaline on resistance, exchange and capacitance functions in the peripheral circulation. Clin. Sci 1970; 39: 183–201
- Müller-Schweinitzer E., Brundell J. Modification of canine vascular smooth muscular responses to dihydroergotamine by endogenous prostaglandin synthesis. Europ. J. Pharmacol 1975; 34: 194–206
- Müller-Schweinitzer E., Brundell J. Enhanced prostaglandin synthesis contributes to the venoconstrictor activity of ergotamine. Blood Vessels 1975; 12: 193–205
- Müller-Schweinitzer E., Stürmer E. Investigations on the mode of action of ergotamine in the isolasted femoral vein of the dog. Brit. J. Pharmacol 1974; 51: 441–6
- Müller-Schweinitzer E., Weidmann H. Basic pharmacological properties. Ergot alkaloids and related compunds, B. Berde, H. O. Schild. Springer Verlag, Berlin, Heidelberg, New York 1978; 87–232
- Silberbauer K., Fitscha P., Sinzinger H. Beeinflussung der Venenwand - Thrombozyten-Interaktion durch Dihydroergotamin. Wien. Klin. Wochenschr 1981; 95: 577–61
- Svanberg L., Bernstein K., Kullander S., Åstedt B. Effect of dihydroergotamine on coagulation factors and components of the fibrinolytic system. Acta Obstet. Gynecol. Scand 1980; 59: 251–5
- Ulrich J., Jessen B., Siggaard-Andersen J. Comparative effects of dihydroergotamine and HyderginR on the blood flow, capillary filtration rate and the capacitance vessels in the human calf studied by plethysmography. Angiology 1973; 24: 657–63
- Wagner H. Metabolic effects. Ergot alkaloids and related compunds, B. Berde, H. O. Schild. Springer Verlag, Berlin, Heidelberg, New York 1978; 691–717